相关实验视频

Updated: May 29, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

儿童分化甲状腺癌中的分子景观和治疗策略

Adeline T Yang^1,2, Sin-Ting Tiffany Lai^2,3, Theodore W Laetsch^1,2

¹Division of Pediatric Oncology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Endocrine reviews

|February 8, 2025

概括

小儿分化甲状腺癌 (DTC) 现在被分为三个分子层,指导风险评估和治疗. 了解这些分子驱动因素有助于优化手术规划和向治疗,以改善患者的治疗结果.

科学领域:

在瘤学瘤学.
遗传学遗传学是一个
儿科儿科儿科

背景情况:

在过去二十年中,了解儿科分化甲状腺癌 (DTC) 的分子基础取得了重大进展.
儿科DTC分类为RAS样突变,BRAF突变和酶融合等级与侵入性潜力和转移风险相关.

研究的目的:

审查风险因素,临床表现和儿科DTC的评估.
为了突出超声波特征,细胞学和瘤瘤驱动因素之间的相关性.
为改善诊断准确性和术前规划提出一个综合的多式联络方法.

主要方法:

关于儿科DTC分子格局,风险因素和临床表现的现有文献的综述.
分析成像 (超声波),细胞病理学 (贝塞斯达系统) 和分子瘤基因状态之间的相关性.
讨论体内瘤基因测试在手术规划和治疗决策中的作用.

主要成果:

实体瘤基因测试提供客观数据,用于在不确定的甲状腺结节中进行手术规划.
了解特定的瘤驱动因素使得针对性疗法在辅助和新辅助设置对侵入性DTC.
一个综合的方法将成像,细胞学和分子驱动因素相关联,提高了诊断准确度.

结论:

儿科DTC的分子分类对于风险分层和治疗指导至关重要.
综合诊断方法改善了手术前的规划和针对性治疗的患者选择.
系统性口服向治疗对选择的儿科DTC患者有希望,基于他们的分子形状.

关键词:

恶性瘤的风险评估.分子疗法的分子疗法.儿科分化的甲状腺癌.

更多相关视频

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...